Kwon SH, Na JI, Choi JY et al (2019) Melasma: Updates and perspectives. Experimental Dermatol 28(6):704–8. https://doi.org/10.1111/exd.13844

Article  Google Scholar 

Passeron T (2013) Melasma pathogenesis and influencing factors - an overview of the latest research. J Eur Acad Dermatol Venereol 27(Suppl 1):5–6. https://doi.org/10.1111/jdv.12049

Article  CAS  PubMed  Google Scholar 

Artzi O, Horovitz T, Bar-Ilan E et al (2021) The pathogenesis of melasma and implications for treatment. J Cosmet Dermatol 20(11):3432–45. https://doi.org/10.1111/jocd.14382

Article  PubMed  Google Scholar 

Piętowska Z, Nowicka D, Szepietowski JC (2022) Understanding melasma-how can pharmacology and cosmetology procedures and prevention help to achieve optimal treatment results? A narrative review. Int J Environ Res Public Health 19(19):12084. https://doi.org/10.3390/ijerph191912084

Espósito ACC, Cassiano DP, da Silva CN et al (2022) Update on Melasma-Part I: Pathogenesis. Dermatol Ther (Heidelb). 12(9):1967–88. https://doi.org/10.1007/s13555-022-00779-x

Article  PubMed  PubMed Central  Google Scholar 

Cassiano DP, Espósito ACC, da Silva CN et al (2022) Update on Melasma-Part II: Treatment. Dermatol Ther (Heidelb). 12(9):1989–2012. https://doi.org/10.1007/s13555-022-00780-4

Article  PubMed  PubMed Central  Google Scholar 

Lai D, Zhou S, Cheng S et al (2022) Laser therapy in the treatment of melasma: a systematic review and meta-analysis. Lasers Med Sci. 37(4):2099–110. https://doi.org/10.1007/s10103-022-03514-2

Article  PubMed  Google Scholar 

Morais OO, Lemos ÉF, Sousa MC et al (2013) The use of ablative lasers in the treatment of facial melasma. An Bras Dermatol. 88(2):238–42. https://doi.org/10.1590/s0365-05962013000200009

Article  PubMed  PubMed Central  Google Scholar 

Ng WHS, Smith SD (2022) Laser-assisted drug delivery: a systematic review of safety and adverse events. Pharmaceutics 14(12):2738. https://doi.org/10.3390/pharmaceutics14122738

Article  CAS  PubMed  PubMed Central  Google Scholar 

Higgins JP, Altman DG, Gøtzsche PC et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj. 343:d5928. https://doi.org/10.1136/bmj.d5928

Article  PubMed  PubMed Central  Google Scholar 

Jalaly NY, Valizadeh N, Barikbin B et al (2014) Low-power fractional CO2 laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study. Am J Clin Dermatol 15(4):357–63. https://doi.org/10.1007/s40257-014-0080-x

Article  PubMed  Google Scholar 

Tawfic SO, Abdel Halim DM, Albarbary A et al (2019) Assessment of combined fractional CO(2) and tranexamic acid in melasma treatment. Lasers Surg Med 51(1):27–33. https://doi.org/10.1002/lsm.23032

Article  PubMed  Google Scholar 

Nourmohammadi Abadchi S, Fatemi Naeini F, Beheshtian E (2019) Combination of Hydroquinone and Fractional CO(2) Laser versus Hydroquinone Monotherapy in Melasma Treatment: A Randomized, Single-blinded. Split-face Clinical Trial Indian J Dermatol 64(2):129–35. https://doi.org/10.4103/ijd.IJD_240_17

Article  PubMed  Google Scholar 

Qu Y, Wang F, Liu J et al (2021) Clinical observation and dermoscopy evaluation of fractional CO(2) laser combined with topical tranexamic acid in melasma treatments. J Cosmet Dermatol 20(4):1110–6. https://doi.org/10.1111/jocd.13992

Article  PubMed  Google Scholar 

Elmorsy E, Aboukhadr N, Tayyeb M et al (2021) Low-power Fractional Carbon Dioxide Laser Followed by Jessner’s Peel versus Jessner’s Peel Alone for the Treatment of Melasma. J Clin Aesthet Dermatol 14(2):61–7

PubMed  PubMed Central  Google Scholar 

Mekawy KMM, Sadek A, Seddeik Abdel-Hameed AK (2021) Micro-needling versus fractional carbon dioxide laser for delivery of tranexamic acid in the treatment of melasma: A split-face study. J Cosmet Dermatol 20(2):460–5. https://doi.org/10.1111/jocd.13537

Article  PubMed  Google Scholar 

Esmat S, Elramly AZ, Shahin D, Hilal RF et al (2021) Combining Low Power Fractional CO(2) With QS-NdYAG Toning in the Treatment of Melasma Reduces the Incidence of Punctate Leukoderma. Lasers Surg Med 53(10):1325–40. https://doi.org/10.1002/lsm.23441

Article  PubMed  Google Scholar 

Tawfic SO, Abdel Hay RM, Abouelazm DI et al (2022) Tranexamic Acid Microinjection Alone Versus Its Combination With Fractional Carbon Dioxide Laser in Melasma Treatment: A Dermoscopic Evaluation. Dermatol Surg. 48(5):556–61. https://doi.org/10.1097/dss.0000000000003423

Article  CAS  PubMed  Google Scholar 

Alavi S, Abolhasani E, Asadi S et al (2017) Combination of Q-Switched Nd:YAG and Fractional Erbium:YAG Lasers in Treatment of Melasma: A Randomized Controlled Clinical Trial. J Lasers Med Sci 8(1):1–6. https://doi.org/10.15171/jlms.2017.01

Article  PubMed  PubMed Central  Google Scholar 

Badawi AM, Osman MA (2018) Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery of hydroquinone in the treatment of melasma. Clin Cosmet Investig Dermatol 11:13–20. https://doi.org/10.2147/ccid.s147413

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garg S, Vashisht KR, Makadia S (2019) A prospective randomized comparative study on 60 Indian patients of melasma, comparing pixel Q-switched NdYAG (1064 nm), super skin rejuvenation (540 nm) and ablative pixel erbium YAG (2940 nm) lasers, with a review of the literature. J Cosmet Laser Ther 21(5):297–307. https://doi.org/10.1080/14764172.2019.1605447

Article  PubMed  Google Scholar 

Al-Dhalimi MA, Yasser RH (2021) Evaluation of the of the efficacy of Fractional Erbium-Doped Yttrium Aluminum Garnet Laser-Assisted Drug Delivery of Kojic Acid in the Treatment of Melasma; A split face, comparative clinical study. J Cosmet Laser Ther 23(3–4):65–71. https://doi.org/10.1080/14764172.2021.1964536

Article  PubMed  Google Scholar 

Nasimi M, Ghiasi M, Lajevardi V et al (2022) A split-face comparison of fractional erbium: YAG laser plus Kligman’s formula vs Kligman’s formula monotherapy for facial melasma. Arch Dermatol Res 314(8):791–7

Article  PubMed  Google Scholar 

Mokhtari F, Bahrami B, Faghihi G et al (2022) Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial. J Dermatolog Treat 33(5):2475–81. https://doi.org/10.1080/09546634.2021.1968996

Article  CAS  PubMed  Google Scholar 

Neagu N, Conforti C, Agozzino M et al (2022) Melasma treatment: a systematic review. J Dermatolog Treat 33(4):1816–37. https://doi.org/10.1080/09546634.2021.1914313

Article  CAS  PubMed  Google Scholar 

Abdel-Raouf Mohamed H, Ali Nasif G, Saad Abdel-Azim E et al (2019) Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma. J Cosmet Dermatol 18(2):517–23. https://doi.org/10.1111/jocd.12751

Article  PubMed  Google Scholar 

El-Sinbawy ZG, Abdelnabi NM, Sarhan NE et al (2019) Clinical & ultrastructural evaluation of the effect of fractional CO2 laser on facial melasma. Ultrastructural pathology 43(4–5):135–44. https://doi.org/10.1080/01913123.2019.1673861

Article  PubMed  Google Scholar 

Hsiao CY, Yang SC, Alalaiwe A et al (2019) Laser ablation and topical drug delivery: a review of recent advances. Expert Opinion Drug Delivery 16(9):937–52. https://doi.org/10.1080/17425247.2019.1649655

Article  CAS  Google Scholar 

Kaufman BP, Aman T, Alexis AF (2018) Postinflammatory Hyperpigmentation: Epidemiology, Clinical Presentation, Pathogenesis and Treatment. Am J Clin Dermatol. 19(4):489–503. https://doi.org/10.1007/s40257-017-0333-6

Article  PubMed  Google Scholar 

Tian WC (2016) Novel technique to treat melasma in Chinese: The combination of 2940-nm fractional Er:YAG and 1064-nm Q-switched Nd:YAG laser. J Cosmet Laser Ther 18(2):72–4. https://doi.org/10.3109/14764172.2015.1063662

Article  PubMed  Google Scholar